• ALOX5 and Ferroptosis Escape in Bladder Cancer

  2026-08-13

  The 2023 Cell Death and Disease study identifies ALOX5 deficiency as a determinant of ferroptosis resistance in bladder cancer and links this defect to EGR1-dependent transcriptional regulation. Its integrated use of stage-stratified models, RNA-seq, RNAi, CRISPR/Cas9, in vivo validation, and clinical associations positions ALOX5 as a candidate biomarker and therapeutic vulnerability, while also clarifying the limits of extrapolating autophagy-focused tools to ferroptosis biology.

• Amplex Red as a Quantitative Enzyme Biosensor

  2026-08-13

  Amplex Red, also known as 10-Acetyl-3,7-dihydroxyphenoxazine, is more than a hydrogen peroxide indicator. This article explains how its HRP-coupled fluorescence can calibrate enzyme activity, reveal spatially immobilized biocatalysts, and guide next-generation biosensor design.

• Cytarabine (AraC): Mechanism and Research Use

  2026-08-13

  Cytarabine, also called AraC, is a deoxycytidine-related nucleoside analog DNA synthesis inhibitor used in leukemia research and chemotherapy studies. Its activity depends on deoxycytidine kinase activation, intracellular phosphorylation, DNA incorporation, and context-specific apoptosis signaling.

• BX795: Reading TBK1–IRF3–Autophagy Signals

  2026-08-12

  BX795 is a versatile PDK1 inhibitor for separating kinase-driven effects on cancer signaling from TBK1–IRF3 innate immune responses. This article develops an assay-interpretation framework grounded in recent HBV research, with practical controls for linking interferon suppression to autophagy.

• Difloxacin HCl: Applied Workflows and Troubleshooting

  2026-08-11

  Difloxacin HCl supports two distinct research workflows: standardized antimicrobial susceptibility testing and exploratory multidrug resistance reversal assays. This practical guide covers preparation, assay design, controls, troubleshooting, and the boundaries between antibacterial evidence and mitotic checkpoint research.

• Auranofin: TrxR Inhibition and Research Use

  2026-08-11

  Auranofin is a thioredoxin reductase inhibitor that perturbs cellular redox homeostasis and supports apoptosis-focused research. Product benchmarks include nanomolar TrxR inhibition, micromolar activity in Helicobacter pylori and cancer-cell models, and radiosensitization in murine tumor systems.

• Rifampin Workflows for Transcription Inhibition

  2026-08-10

  Rifampin gives researchers a mechanistically focused way to interrupt bacterial transcription, making it useful for resistance mapping, RNA turnover studies, and synthetic biology controls. This workflow-oriented guide covers stock preparation, exposure design, assay selection, and troubleshooting around solubility, timing, and growth-state effects.

• Live-Dead Cell Staining Kit I for TNBC Assays

  2026-08-09

  Turn treatment-response experiments into interpretable two-color viability maps with Calcein AM/PI staining. This workflow is especially useful for mammalian oncology models, where rapid live/dead imaging can complement ferroptosis-focused molecular and biochemical measurements.

• Dimethyloxalylglycine (DMOG) Protocol Guide

  2026-08-08

  Dimethyloxalylglycine (DMOG), SKU A4506, provides a practical chemical approach for hypoxia-inducible factor stabilization in cell-based oxygen-sensing, hypoxia signaling, and inflammation studies. It is intended for controlled scientific research and preclinical models only, not for diagnostic, therapeutic, or other clinical use.

• Tauroursodeoxycholic Acid in ER Stress Assays

  2026-08-07

  Tauroursodeoxycholic Acid (TUDCA) gives researchers a practical way to connect ER proteostasis, mitochondrial stability, and apoptosis in one experimental design. This guide shows how to deploy it as a pathway-modulating comparator in neuroinflammation, metabolic, and regenerative medicine workflows while avoiding common interpretation and formulation errors.

• URB597 (KDS-4103): Precision FAAH Inhibition for Pain Models

  2026-08-07

  URB597 (KDS-4103) enables highly selective, reproducible inhibition of FAAH for dissecting endocannabinoid signaling, especially in neuroinflammation and sensory pain research. This guide translates cutting-edge findings—including CBD-driven FAAH modulation—into robust workflows, practical assay enhancements, and troubleshooting tips for preclinical neuroscience.

• Substance P: Key Tachykinin Neuropeptide for Pain Transmissi

  2026-08-06

  Substance P is a prototypical tachykinin neuropeptide central to pain transmission and neuroimmune modulation. It acts via neurokinin-1 receptors to influence inflammation and immune responses. APExBIO's high-purity Substance P enables reproducible CNS research.

• DNase I (RNase-free): Precision DNA Removal for RNA Extracti

  2026-08-06

  DNase I (RNase-free) from APExBIO empowers researchers to achieve robust DNA removal, enabling high-purity RNA prep, accurate RT-PCR, and advanced 3D co-culture modeling. Its RNase-free assurance and cation-tunable specificity make it an indispensable tool for workflows demanding uncompromised RNA integrity and reproducibility.

• Direct Mouse Genotyping Kit Plus: Precision in Complex Mouse

  2026-08-05

  Unlock advanced genetic insights with the Direct Mouse Genotyping Kit Plus. This article explores how its high-fidelity workflow empowers cutting-edge mouse genotyping, with a unique focus on macrophage plasticity studies and complex lineage tracing.

• SB-505124 Hydrochloride: Precision Inhibitor for Fibrosis Re

  2026-08-05

  SB-505124 hydrochloride stands out as a selective TGF-β/activin pathway inhibitor, enabling reproducible modulation of Smad2/3 phosphorylation in fibrosis and mechanobiology models. Its robust solubility, non-cytotoxicity, and validated performance in both in vitro and in vivo workflows empower researchers to dissect complex signaling with confidence.

451 records 8/31 page Previous Next First page 上5页 678910 下5页 Last page